Industry Research Reports

Home > Reports > Chemical & Material > Dehydroepiandrosterone (DHEA) Intermediates - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Dehydroepiandrosterone (DHEA) Intermediates - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published: 2025-03-14

Pages: 94 Pages

Report ld: 4668822

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Dehydroepiandrosterone (DHEA) Intermediates was estimated to be worth US$ 49.3 million in 2024 and is forecast to a readjusted size of US$ 75.9 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.

Dehydroepiandrosterone is an endogenous steroid hormone that is mainly secreted by the adrenal glands, as well as the gonads and brain. It is the most common steroid hormone in the human peripheral circulation.

Dehydroepiandrosterone (DHEA) Intermediates Market Size(US$)

M= millions and B=billions

North American market for Dehydroepiandrosterone (DHEA) Intermediates was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Dehydroepiandrosterone (DHEA) Intermediates was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Dehydroepiandrosterone (DHEA) Intermediates was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Dehydroepiandrosterone (DHEA) Intermediates include Yicheng Goto Pharmaceuticals Co.,Ltd., Junye Pharmaceutical Co., Ltd., Zhejiang Shenzhou Pharmaceutical Co., Ltd., Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd., Jiangsu Jiaerke Pharmaceuticals Group Corp., Hubei Dan’ao Pharmaceutical Co., Ltd., Wudang Antai Pharmaceutical Co., Ltd., Shandong Saito Biotechnology Co., Ltd., NutriScience Innovations, LLC, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Dehydroepiandrosterone (DHEA) Intermediates, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dehydroepiandrosterone (DHEA) Intermediates by region & country, by Type, and by Application.

The Dehydroepiandrosterone (DHEA) Intermediates market size, estimations, and forecasts are provided in terms of sales volume (kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dehydroepiandrosterone (DHEA) Intermediates.

Market Segmentation

Report Metric
Details
Report Title
Dehydroepiandrosterone (DHEA) Intermediates - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Forecasted Market Size in 2031
US$ 75.9 million
CAGR(2025-2031)
7.2%
Market Size Available for Years
2020-2031
Global Dehydroepiandrosterone (DHEA) Intermediates Companies Covered
Yicheng Goto Pharmaceuticals Co.,Ltd., Junye Pharmaceutical Co., Ltd., Zhejiang Shenzhou Pharmaceutical Co., Ltd., Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd., Jiangsu Jiaerke Pharmaceuticals Group Corp., Hubei Dan’ao Pharmaceutical Co., Ltd., Wudang Antai Pharmaceutical Co., Ltd., Shandong Saito Biotechnology Co., Ltd., NutriScience Innovations, LLC
Global Dehydroepiandrosterone (DHEA) Intermediates Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dehydroepiandrosterone (DHEA) Intermediates Market, Segment by Type
≥ 99％

Others
Global Dehydroepiandrosterone (DHEA) Intermediates Market, Segment by Application
Medicine

Dietary Supplements

Skin Care Products

Reagents

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Dehydroepiandrosterone (DHEA) Intermediates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Dehydroepiandrosterone (DHEA) Intermediates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Dehydroepiandrosterone (DHEA) Intermediates in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Dehydroepiandrosterone (DHEA) Intermediates Product Introduction
    1.2 Global Dehydroepiandrosterone (DHEA) Intermediates Market Size Forecast
        1.2.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value (2020-2031)
        1.2.2 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume (2020-2031)
        1.2.3 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Price (2020-2031)
    1.3 Dehydroepiandrosterone (DHEA) Intermediates Market Trends & Drivers
        1.3.1 Dehydroepiandrosterone (DHEA) Intermediates Industry Trends
        1.3.2 Dehydroepiandrosterone (DHEA) Intermediates Market Drivers & Opportunity
        1.3.3 Dehydroepiandrosterone (DHEA) Intermediates Market Challenges
        1.3.4 Dehydroepiandrosterone (DHEA) Intermediates Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Dehydroepiandrosterone (DHEA) Intermediates Players Revenue Ranking (2024)
    2.2 Global Dehydroepiandrosterone (DHEA) Intermediates Revenue by Company (2020-2025)
    2.3 Global Dehydroepiandrosterone (DHEA) Intermediates Players Sales Volume Ranking (2024)
    2.4 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Company Players (2020-2025)
    2.5 Global Dehydroepiandrosterone (DHEA) Intermediates Average Price by Company (2020-2025)
    2.6 Key Manufacturers Dehydroepiandrosterone (DHEA) Intermediates Manufacturing Base and Headquarters
    2.7 Key Manufacturers Dehydroepiandrosterone (DHEA) Intermediates Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Dehydroepiandrosterone (DHEA) Intermediates
    2.9 Dehydroepiandrosterone (DHEA) Intermediates Market Competitive Analysis
        2.9.1 Dehydroepiandrosterone (DHEA) Intermediates Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by Dehydroepiandrosterone (DHEA) Intermediates Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dehydroepiandrosterone (DHEA) Intermediates as of 2024)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 ≥ 99％
        3.1.2 Others
    3.2 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type
        3.2.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value, by Type (2020-2031)
        3.2.3 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value, by Type (%) (2020-2031)
    3.3 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Type
        3.3.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume, by Type (2020-2031)
        3.3.3 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume, by Type (%) (2020-2031)
    3.4 Global Dehydroepiandrosterone (DHEA) Intermediates Average Price by Type (2020-2031)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Medicine
        4.1.2 Dietary Supplements
        4.1.3 Skin Care Products
        4.1.4 Reagents
        4.1.5 Others
    4.2 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application
        4.2.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value, by Application (2020-2031)
        4.2.3 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value, by Application (%) (2020-2031)
    4.3 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Application
        4.3.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume, by Application (2020-2031)
        4.3.3 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume, by Application (%) (2020-2031)
    4.4 Global Dehydroepiandrosterone (DHEA) Intermediates Average Price by Application (2020-2031)

 5 Segmentation by Region
    5.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Region
        5.1.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Region (2020-2025)
        5.1.3 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Region (2026-2031)
        5.1.4 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Region (%), (2020-2031)
    5.2 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Region
        5.2.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Region (2020-2025)
        5.2.3 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Region (2026-2031)
        5.2.4 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Region (%), (2020-2031)
    5.3 Global Dehydroepiandrosterone (DHEA) Intermediates Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        5.4.2 North America Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        5.5.2 Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        5.6.2 Asia Pacific Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        5.7.2 South America Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        5.8.2 Middle East & Africa Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Country (%), 2024 VS 2031

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Dehydroepiandrosterone (DHEA) Intermediates Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Dehydroepiandrosterone (DHEA) Intermediates Sales Value and Sales Volume
        6.2.1 Key Countries/Regions Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        6.2.2 Key Countries/Regions Dehydroepiandrosterone (DHEA) Intermediates Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        6.3.2 United States Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        6.4.2 Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        6.5.2 China Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        6.6.2 Japan Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        6.7.2 South Korea Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        6.8.2 Southeast Asia Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020-2031
        6.9.2 India Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application, 2024 VS 2031

 7 Company Profiles
    7.1 Yicheng Goto Pharmaceuticals Co.,Ltd.
        7.1.1 Yicheng Goto Pharmaceuticals Co.,Ltd. Company Information
        7.1.2 Yicheng Goto Pharmaceuticals Co.,Ltd. Introduction and Business Overview
        7.1.3 Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
        7.1.5 Yicheng Goto Pharmaceuticals Co.,Ltd. Recent Development
    7.2 Junye Pharmaceutical Co., Ltd.
        7.2.1 Junye Pharmaceutical Co., Ltd. Company Information
        7.2.2 Junye Pharmaceutical Co., Ltd. Introduction and Business Overview
        7.2.3 Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
        7.2.5 Junye Pharmaceutical Co., Ltd. Recent Development
    7.3 Zhejiang Shenzhou Pharmaceutical Co., Ltd.
        7.3.1 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Company Information
        7.3.2 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Introduction and Business Overview
        7.3.3 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
        7.3.5 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Recent Development
    7.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
        7.4.1 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Company Information
        7.4.2 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Introduction and Business Overview
        7.4.3 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
        7.4.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
        7.4.5 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Recent Development
    7.5 Jiangsu Jiaerke Pharmaceuticals Group Corp.
        7.5.1 Jiangsu Jiaerke Pharmaceuticals Group Corp. Company Information
        7.5.2 Jiangsu Jiaerke Pharmaceuticals Group Corp. Introduction and Business Overview
        7.5.3 Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
        7.5.4 Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
        7.5.5 Jiangsu Jiaerke Pharmaceuticals Group Corp. Recent Development
    7.6 Hubei Dan’ao Pharmaceutical Co., Ltd.
        7.6.1 Hubei Dan’ao Pharmaceutical Co., Ltd. Company Information
        7.6.2 Hubei Dan’ao Pharmaceutical Co., Ltd. Introduction and Business Overview
        7.6.3 Hubei Dan’ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
        7.6.4 Hubei Dan’ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
        7.6.5 Hubei Dan’ao Pharmaceutical Co., Ltd. Recent Development
    7.7 Wudang Antai Pharmaceutical Co., Ltd.
        7.7.1 Wudang Antai Pharmaceutical Co., Ltd. Company Information
        7.7.2 Wudang Antai Pharmaceutical Co., Ltd. Introduction and Business Overview
        7.7.3 Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
        7.7.4 Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
        7.7.5 Wudang Antai Pharmaceutical Co., Ltd. Recent Development
    7.8 Shandong Saito Biotechnology Co., Ltd.
        7.8.1 Shandong Saito Biotechnology Co., Ltd. Company Information
        7.8.2 Shandong Saito Biotechnology Co., Ltd. Introduction and Business Overview
        7.8.3 Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
        7.8.4 Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
        7.8.5 Shandong Saito Biotechnology Co., Ltd. Recent Development
    7.9 NutriScience Innovations, LLC
        7.9.1 NutriScience Innovations, LLC Company Information
        7.9.2 NutriScience Innovations, LLC Introduction and Business Overview
        7.9.3 NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
        7.9.4 NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
        7.9.5 NutriScience Innovations, LLC Recent Development

 8 Industry Chain Analysis
    8.1 Dehydroepiandrosterone (DHEA) Intermediates Industrial Chain
    8.2 Dehydroepiandrosterone (DHEA) Intermediates Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Dehydroepiandrosterone (DHEA) Intermediates Sales Model
        8.5.2 Sales Channel
        8.5.3 Dehydroepiandrosterone (DHEA) Intermediates Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Dehydroepiandrosterone (DHEA) Intermediates Market Trends
 Table 2. Dehydroepiandrosterone (DHEA) Intermediates Market Drivers & Opportunity
 Table 3. Dehydroepiandrosterone (DHEA) Intermediates Market Challenges
 Table 4. Dehydroepiandrosterone (DHEA) Intermediates Market Restraints
 Table 5. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Market Share by Company (2020-2025)
 Table 7. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Company (2020-2025) & (kg)
 Table 8. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Dehydroepiandrosterone (DHEA) Intermediates Price by Company (2020-2025) & (US$/kg)
 Table 10. Key Manufacturers Dehydroepiandrosterone (DHEA) Intermediates Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Dehydroepiandrosterone (DHEA) Intermediates Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Dehydroepiandrosterone (DHEA) Intermediates
 Table 13. Global Dehydroepiandrosterone (DHEA) Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dehydroepiandrosterone (DHEA) Intermediates as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Type: 2020 VS 2024 VS 2031 (kg)
 Table 22. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Type (2020-2025) & (kg)
 Table 23. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Type (2026-2031) & (kg)
 Table 24. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Dehydroepiandrosterone (DHEA) Intermediates Price by Type (2020-2025) & (US$/kg)
 Table 27. Global Dehydroepiandrosterone (DHEA) Intermediates Price by Type (2026-2031) & (US$/kg)
 Table 28. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Application: 2020 VS 2024 VS 2031 (kg)
 Table 34. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Application (2020-2025) & (kg)
 Table 35. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Application (2026-2031) & (kg)
 Table 36. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Dehydroepiandrosterone (DHEA) Intermediates Price by Application (2020-2025) & (US$/kg)
 Table 39. Global Dehydroepiandrosterone (DHEA) Intermediates Price by Application (2026-2031) & (US$/kg)
 Table 40. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Region (2020-2025) & (%)
 Table 44. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Region (2026-2031) & (%)
 Table 45. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Region (kg): 2020 VS 2024 VS 2031
 Table 46. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Region (2020-2025) & (kg)
 Table 47. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Region (2026-2031) & (kg)
 Table 48. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Dehydroepiandrosterone (DHEA) Intermediates Average Price by Region (2020-2025) & (US$/kg)
 Table 51. Global Dehydroepiandrosterone (DHEA) Intermediates Average Price by Region (2026-2031) & (US$/kg)
 Table 52. Key Countries/Regions Dehydroepiandrosterone (DHEA) Intermediates Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Dehydroepiandrosterone (DHEA) Intermediates Sales Volume, (2020-2025) & (kg)
 Table 56. Key Countries/Regions Dehydroepiandrosterone (DHEA) Intermediates Sales Volume, (2026-2031) & (kg)
 Table 57. Yicheng Goto Pharmaceuticals Co.,Ltd. Company Information
 Table 58. Yicheng Goto Pharmaceuticals Co.,Ltd. Introduction and Business Overview
 Table 59. Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 60. Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
 Table 61. Yicheng Goto Pharmaceuticals Co.,Ltd. Recent Development
 Table 62. Junye Pharmaceutical Co., Ltd. Company Information
 Table 63. Junye Pharmaceutical Co., Ltd. Introduction and Business Overview
 Table 64. Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 65. Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
 Table 66. Junye Pharmaceutical Co., Ltd. Recent Development
 Table 67. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Company Information
 Table 68. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Introduction and Business Overview
 Table 69. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 70. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
 Table 71. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Recent Development
 Table 72. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Company Information
 Table 73. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Introduction and Business Overview
 Table 74. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 75. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
 Table 76. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Recent Development
 Table 77. Jiangsu Jiaerke Pharmaceuticals Group Corp. Company Information
 Table 78. Jiangsu Jiaerke Pharmaceuticals Group Corp. Introduction and Business Overview
 Table 79. Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 80. Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
 Table 81. Jiangsu Jiaerke Pharmaceuticals Group Corp. Recent Development
 Table 82. Hubei Dan’ao Pharmaceutical Co., Ltd. Company Information
 Table 83. Hubei Dan’ao Pharmaceutical Co., Ltd. Introduction and Business Overview
 Table 84. Hubei Dan’ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 85. Hubei Dan’ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
 Table 86. Hubei Dan’ao Pharmaceutical Co., Ltd. Recent Development
 Table 87. Wudang Antai Pharmaceutical Co., Ltd. Company Information
 Table 88. Wudang Antai Pharmaceutical Co., Ltd. Introduction and Business Overview
 Table 89. Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 90. Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
 Table 91. Wudang Antai Pharmaceutical Co., Ltd. Recent Development
 Table 92. Shandong Saito Biotechnology Co., Ltd. Company Information
 Table 93. Shandong Saito Biotechnology Co., Ltd. Introduction and Business Overview
 Table 94. Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 95. Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
 Table 96. Shandong Saito Biotechnology Co., Ltd. Recent Development
 Table 97. NutriScience Innovations, LLC Company Information
 Table 98. NutriScience Innovations, LLC Introduction and Business Overview
 Table 99. NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 100. NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Intermediates Product Offerings
 Table 101. NutriScience Innovations, LLC Recent Development
 Table 102. Key Raw Materials Lists
 Table 103. Raw Materials Key Suppliers Lists
 Table 104. Dehydroepiandrosterone (DHEA) Intermediates Downstream Customers
 Table 105. Dehydroepiandrosterone (DHEA) Intermediates Distributors List
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources


List of Figures
 Figure 1. Dehydroepiandrosterone (DHEA) Intermediates Product Picture
 Figure 2. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume (2020-2031) & (kg)
 Figure 5. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Price (2020-2031) & (US$/kg)
 Figure 6. Dehydroepiandrosterone (DHEA) Intermediates Report Years Considered
 Figure 7. Global Dehydroepiandrosterone (DHEA) Intermediates Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Dehydroepiandrosterone (DHEA) Intermediates Players Sales Volume Ranking (2024) & (kg)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dehydroepiandrosterone (DHEA) Intermediates Revenue in 2024
 Figure 10. Dehydroepiandrosterone (DHEA) Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. ≥ 99％ Picture
 Figure 12. Others Picture
 Figure 13. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 14. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value Market Share by Type, 2024 & 2031
 Figure 15. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Type (2020 VS 2024 VS 2031) & (kg)
 Figure 16. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume Market Share by Type, 2024 & 2031
 Figure 17. Global Dehydroepiandrosterone (DHEA) Intermediates Price by Type (2020-2031) & (US$/kg)
 Figure 18. Product Picture of Medicine
 Figure 19. Product Picture of Dietary Supplements
 Figure 20. Product Picture of Skin Care Products
 Figure 21. Product Picture of Reagents
 Figure 22. Product Picture of Others
 Figure 23. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 24. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Value Market Share by Application, 2024 & 2031
 Figure 25. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume by Application (2020 VS 2024 VS 2031) & (kg)
 Figure 26. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Volume Market Share by Application, 2024 & 2031
 Figure 27. Global Dehydroepiandrosterone (DHEA) Intermediates Price by Application (2020-2031) & (US$/kg)
 Figure 28. North America Dehydroepiandrosterone (DHEA) Intermediates Sales Value (2020-2031) & (US$ Million)
 Figure 29. North America Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Country (%), 2024 VS 2031
 Figure 30. Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Country (%), 2024 VS 2031
 Figure 32. Asia Pacific Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Region (%), 2024 VS 2031
 Figure 34. South America Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2020-2031) & (US$ Million)
 Figure 35. South America Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Country (%), 2024 VS 2031
 Figure 36. Middle East & Africa Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2020-2031) & (US$ Million)
 Figure 37. Middle East & Africa Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Country (%), 2024 VS 2031
 Figure 38. Key Countries/Regions Dehydroepiandrosterone (DHEA) Intermediates Sales Value (%), (2020-2031)
 Figure 39. Key Countries/Regions Dehydroepiandrosterone (DHEA) Intermediates Sales Volume (%), (2020-2031)
 Figure 40. United States Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2020-2031) & (US$ Million)
 Figure 41. United States Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
 Figure 42. United States Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application (%), 2024 VS 2031
 Figure 43. Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2020-2031) & (US$ Million)
 Figure 44. Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
 Figure 45. Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application (%), 2024 VS 2031
 Figure 46. China Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2020-2031) & (US$ Million)
 Figure 47. China Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
 Figure 48. China Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application (%), 2024 VS 2031
 Figure 49. Japan Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2020-2031) & (US$ Million)
 Figure 50. Japan Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
 Figure 51. Japan Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application (%), 2024 VS 2031
 Figure 52. South Korea Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2020-2031) & (US$ Million)
 Figure 53. South Korea Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
 Figure 54. South Korea Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application (%), 2024 VS 2031
 Figure 55. Southeast Asia Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2020-2031) & (US$ Million)
 Figure 56. Southeast Asia Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
 Figure 57. Southeast Asia Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application (%), 2024 VS 2031
 Figure 58. India Dehydroepiandrosterone (DHEA) Intermediates Sales Value, (2020-2031) & (US$ Million)
 Figure 59. India Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Type (%), 2024 VS 2031
 Figure 60. India Dehydroepiandrosterone (DHEA) Intermediates Sales Value by Application (%), 2024 VS 2031
 Figure 61. Dehydroepiandrosterone (DHEA) Intermediates Industrial Chain
 Figure 62. Dehydroepiandrosterone (DHEA) Intermediates Manufacturing Cost Structure
 Figure 63. Channels of Distribution (Direct Sales, and Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed

Description

The global market for Dehydroepiandrosterone (DHEA) Intermediates was estimated to be worth US$ 49.3 million in 2024 and is forecast to a readjusted size of US$ 75.9 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.

Dehydroepiandrosterone is an endogenous steroid hormone that is mainly secreted by the adrenal glands, as well as the gonads and brain. It is the most common steroid hormone in the human peripheral circulation.

North American market for Dehydroepiandrosterone (DHEA) Intermediates was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Dehydroepiandrosterone (DHEA) Intermediates was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Dehydroepiandrosterone (DHEA) Intermediates was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Dehydroepiandrosterone (DHEA) Intermediates include Yicheng Goto Pharmaceuticals Co.,Ltd., Junye Pharmaceutical Co., Ltd., Zhejiang Shenzhou Pharmaceutical Co., Ltd., Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd., Jiangsu Jiaerke Pharmaceuticals Group Corp., Hubei Dan’ao Pharmaceutical Co., Ltd., Wudang Antai Pharmaceutical Co., Ltd., Shandong Saito Biotechnology Co., Ltd., NutriScience Innovations, LLC, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Dehydroepiandrosterone (DHEA) Intermediates, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dehydroepiandrosterone (DHEA) Intermediates by region & country, by Type, and by Application.

The Dehydroepiandrosterone (DHEA) Intermediates market size, estimations, and forecasts are provided in terms of sales volume (kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dehydroepiandrosterone (DHEA) Intermediates.

Market Segmentation